- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 12- Comparing Current Healthcare Spending to Patient Outcomes
During this discussion about healthcare spending, the panelists debate whether or not current spending is proportional to the current improvements in patient outcomes.
David Calabrese, RPh, MHP, is not convinced that spending and patient outcomes are proportional, and explains that although there have been modest improvements, he feels that from a managed care standpoint factors such as the aging population are of concern.
Agreeing with Mr Calabrese, Kenneth L. Schaecher, MD, FACP, CPC, states that the debate remains that patients are getting the same value of care in relation to the dollars being spent. Dr Schaecher explains that a healthcare misalignment exists because the price of drugs keeps rising. Dr Schaecher continues by saying that pharmaceutical companies are doing their job and are bringing drugs to the market to treat conditions; however, the prices are rising because of the financial demands of their investors.
Yehuda Handelsman, MD, FACP, FACE, FNLA, concludes that issues remain, and feels that a 2-tier system may become necessary in this country to help preserve medical care.
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
